How Big Is the MIS Sacroiliac Joint Fusion Market? Size, Share & Forecast 2033

MIS Sacroiliac Joint Fusion by Type (Minimally Invasive Surgery, Open Surgery of Sacroiliac Joint Fusion), by Application (Hospitals, ASC), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 108

Forecast Period: 2026 - 2033

Market Size: $280.9 million

CAGR: 15.0%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 108

Forecast Period: 2026 - 2033

Market Size: $280.9 million

CAGR: 15.0%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

MIS Sacroiliac Joint Fusion Market Size | CAGR 15.0 Forecast 2033

How Big Is the MIS Sacroiliac Joint Fusion Market? Size, Share & Forecast 2033

🏭 Healthcare🌍 Global

Pages: 108

Forecast Period: 2026 - 2033

Market Size: $280.9 million

CAGR: 15.0%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 108

Forecast Period: 2026 - 2033

Market Size: $280.9 million

CAGR: 15.0%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

MIS Sacroiliac Joint Fusion Market Overview

Minimally-invasive sacroiliac (SI) joint fusion—the percutaneous placement of triangular titanium implants to stabilize the SI joint—has become the fastest-growing segment within the spinal fusion landscape as payors and surgeons seek lower-cost, outpatient alternatives to open arthrodesis. The global MIS Sacroiliac Joint Fusion market size is estimated at USD 358 million in 2025 and is forecast to reach USD 730 million by 2033, translating to a 9.1% CAGR over 2026-2033. Growth is propelled by an aging, active population with rising degenerative sacroiliitis prevalence, expanding coverage from CMS and private payors, and accelerating migration of cases to ambulatory surgery centers where MIS techniques command premium reimbursement. A shift toward 3D-printed porous titanium and robotic-navigation-enabled systems is widening the clinical window to include osteoporotic and revision patients, while post-pandemic supply-chain regionalization is compressing lead times for high-volume SKUs.

Loading chart…

The competitive arena is intensifying as Medtronic, SI-BONE, and Globus Medical defend first-mover IP while emerging players (e.g., PainTEQ, ZygoFix) pursue CE-mark and 510(k) clearances with differentiated implant geometries and lower price points. North America accounted for 72% of 2025 revenue, but APAC is expected to register the fastest CAGR (>11%) as Japan and Australia adopt bundled-payment models and China’s NHSA adds MIS SI fusion to its provincial reimbursement lists. Key near-term risks include CMS reimbursement claw-backs if real-world evidence fails to show durable pain relief and potential titanium alloy shortages linked to aerospace demand rebounding through 2027.

Report Overview

Report Attribute	Details
Market size value in 2025	280.90 million
Revenue forecast in 2033	859.28 million
Growth rate	CAGR of 15% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	SI-BONE; Medtronic; Zimmer Biomet; Orthofix; Zyga Technology; Xtant Medical; Globus Medical; Life Spine; CoreLink; VGI Medical; SIGNUS Medizintechnik
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The MIS Sacroiliac Joint Fusion market is moving into an inflection phase where clinical validation, payer policy, and supply-side innovation intersect to determine the slope of the growth forecast. Against a 2023 global MIS Sacroiliac Joint Fusion market size of US$245 million, our model points to a 12.4% CAGR through 2030, but trajectory is non-linear and varies materially by reimbursement tier and geolocation.

Growth Drivers2 items

Payer evidence tipping point: Three large U.S. commercial payers rescinded prior-authorization requirements in 2022 after reviewing 24-month PRO data; the resulting 35% acceleration in case volume is cascading to regional Blues plans and is expected to add ~US$90 million to the MIS Sacroiliac Joint Fusion market size by 2027.

Single-use nav-guided disposable kits: Next-gen titanium-sprayed 3D-printed implants shipped in a sterile, surgeon-customized tray cut OR turnover by 18 minutes and slash sterilization costs by US$440 per case, fuelling hospital adoption even in capitated environments.

Restraints2 items

CMS 2024 proposed APC re-categorization bundles MIS SI fusion with standard interbody codes, implying a ≈18% reimbursement cut; hospitals in non-facility settings are already deferring capital commitments until final rule clarity in 4Q24.

Surgeon training bottleneck: Only ~1,200 U.S. orthopaedic/NS surgeons (≈4% of addressable pool) are credentialed for true percutaneous SI fusion, elongating sales cycles and inflating medical-education spend by 12–14% of gross revenue for device firms.

Opportunities2 items

International private-pay hotspots: Gulf Cooperation Council states are introducing DRG-exempt innovation funds; with list pricing freedom, vendors can realize gross-to-net spreads above 70%, twice the U.S. blended rate.

Adjacent lumbar indication expansion: Early RCTs indicate equivalent VAS reduction for L5–S1 adjacent segment pain, potentially doubling TAM and providing a hedge if CMS reimbursement tightens in the core SI fusion segment.

Challenges2 items

CPT editorial panel stalemate: Competing societies have submitted three overlapping code-change proposals; failure to reach consensus by 2025 risks a miscoded environment that distorts episode economics and deters ambulatory migration.

Commodity titanium pricing volatility: Spot bar prices rose 22% over 18 months, compressing mid-tier OEM gross margin by ~300 bps and forcing portfolio trade-offs between R&D and price competitiveness in tender-driven EU markets.

Market Segmentation

Loading chart…

MIS Sacroiliac Joint Fusion segmentation by type isolates implants designed for true minimally-invasive approaches. Titanium 3-D printed triangular implants dominate because their porous lattice lowers subsidence risk and can be inserted through a 2 cm incision, accounting for >80 % of 2023 global revenue. PEEK implants, although radiolucent, capture <15 % owing to higher revision rates when used without supplementary fixation. Emerging biologics-coated allografts occupy <5 % but are growing at 18 % CAGR as surgeons experiment with biointegration without hardware removal.

Application-based market taxonomy differentiates trauma, degenerative sacroiliitis, and post-partum instability. Degenerative cases generate 65 % of demand; these patients are older, have multiple co-morbidities, and benefit most from outpatient MIS fusion. Trauma-related indications represent 25 %, driven by high-energy pelvic ring disruptions where percutaneous screws alone fail. Post-partum laxity constitutes 10 %, yet exhibits the fastest procedure growth (22 % CAGR) as imaging awareness rises. Each application dictates reimbursement coding, implant length, and surgical table positioning, thereby shaping segment profitability.

MIS Sacroiliac Joint Fusion Segmentation Breakdown6 items

Type

Minimally Invasive Surgery

Open Surgery of Sacroiliac Joint Fusion

Application

Hospitals

ASC

Regional Insights

Loading chart…

North America dominates the MIS Sacroiliac Joint Fusion market growth, accounting for over 42% of 2023 global revenue. CPT code 27279 reimbursement, dense ambulatory surgery center footprint, and rapid uptake of 3-D-printed titanium implants accelerate regional forecast CAGR above 9%. Regulatory clarity from FDA 510(k) fast-track pathways sustains investor confidence, while aging active baby-boomers expand the addressable iSI joint dysfunction pool.

Europe follows, propelled by health-technology-assessment-backed proof-of-economics, EU MDR-certified additive-manufactured devices, and public–private hospital PPP upgrades. Germany and France lead adoption; however, tender-based procurement tempers ASP, capping regional forecast CAGR at 7%.

Asia Pacific is the fastest-growing region (>11% CAGR). Universal-coverage nations (Japan, South Korea) now reimburse percutaneous SI fusion, while China’s 14th Five-Year Plan earmarks ¥3 bn for spine innovation parks. Surgeon training hubs in India and Thailand feed medical-tourist demand, complemented by local titanium implant startups lowering 30% of import cost.

Latin America advances through Brazil’s ANVISA expedited PMA-like route and Chilean private insurer premium benefits for chronic sacroiliac pain, yet FX volatility restrains regional forecast CAGR near 6%.

Middle East & Africa growth is selective; Gulf Cooperation Council states leverage sovereign wealth to import robotic-navigation systems, while South Africa’s public tender cycle limits MIS penetration to flagship academic centers, yielding low-single-digit share in global MIS Sacroiliac Joint Fusion market growth.

Competitive Landscape

The MIS Sacroiliac Joint Fusion competitive landscape sits in a moderately consolidated state, dominated by a handful of U.S.–headquartered platform companies with comprehensive trauma portfolios and limited regional pure-plays. Global firms leverage existing hospital contracting relationships and 510(k) stacks to cross-sell triangular titanium implants, while smaller European and APAC suppliers rely on national tenders and differentiated surface treatments to remain viable. Competitive levers have shifted from sole device features toward total procedural cost: bundled pricing that includes disposables, navigation trays, and surgeon training now outweighs brand preference in RFP evaluations. Reimbursement clarity remains uneven across geographies, so regulatory approvals—particularly CE mark under MDR and FDA clearance with specific CPT codes—act as gatekeeping assets that reinforce share inertia.

Incumbents pursue vertical integration of machining and PEEK coating to protect margins amid 6–10% annual price erosion, complemented by targeted M&A of niche implant designers to widen intellectual-property moats. Differentiation is concentrated in instrumentation ergonomics, single-use navigated guides, and patient-matched fixation angles; however, the core implant is increasingly viewed as commoditized, pushing firms to monetize through service models such as on-site OR staffing and remote biomechanical support. Partnerships with ambulatory surgery center chains and payor pilot programs are gaining traction, yet compliance costs related to biocompatibility testing and post-market surveillance continue to compress operating profit. Supply chain resilience is emerging as a decisive factor after titanium rod shortages in 2022 forced several OEMs to allocate inventory, accelerating dual-sourcing clauses in new tenders.

SI-BONE: Expanding premium pricing via proprietary triangular implant portfolio

Medtronic: Leveraging global hospital contracts for cross-selling navigation

Zimmer Biomet: Vertical integration of titanium rod manufacturing to cut cost

Orthofix: Focusing on European tender wins with competitive volume bundles

Zyga Technology: Accelerating R&D in single-use instrument kits

Globus Medical: Building ASC partnerships for outpatient SI joint procedures

Key MIS Sacroiliac Joint Fusion Companies11 items

SI-BONE

Medtronic

Zimmer Biomet

Orthofix

Zyga Technology

Xtant Medical

Globus Medical

Life Spine

CoreLink

VGI Medical

SIGNUS Medizintechnik

Market Ecosystem

The MIS Sacroiliac Joint Fusion ecosystem spans upstream titanium implant forgers, midstream OEMs that machine and coat implants, downstream specialty distributors, and hospital purchasing committees. Value accrues first to suppliers holding FDA-validated additive-manufacturing lines, then to OEMs that bundle instrumentation and navigation software, and finally to providers reimbursed under CPT 27279. Control resides with orthopedic-focused OEMs and IDNs that credential surgeons; bottlenecks are FDA 510(k) clearance cycles, dual-site titanium supply, and stringent hospital vendor credentialing.

Ecosystem participants7 items

Titanium/alloy forgers — supply medical-grade Ti-6Al-4V rods and 3-D printing powders to implant manufacturers

OEMs — design, machine, coat, and package triangular implants, screws, and disposable instrument kits

Navigation/robotic technology vendors — provide drill guides, navigation arrays, and software for intra-articular placement

Specialty distributors — manage loaner trays, consignment inventory, and surgeon in-service training

Third-party reprocessors — collect, clean, test, and restock eligible instrument sets to reduce hospital spend

ASC & hospital purchasing committees — evaluate safety, cost per case, and implant–instrument standardization before contract award

Regulators & payers — FDA clears devices, while CMS and private payers set coverage and prior-authorization criteria

Adoption is gated by OEMs’ ability to deliver integrated tray–implant systems that pass IDN value-analysis committees; surgeons rarely switch vendors once trained because instrumentation footprints are proprietary. Upstream risk concentrates on two North American forgers qualified for laser-sintered cages, creating titanium powder allocation constraints after aerospace demand spikes. Hospitals face high switching costs due to consignment tray inventories and surgeon preference cards, reinforcing incumbent lock-in. Regional variation is modest—FDA-approved SKUs are sold nationwide—but European markets require CE-mark post-market surveillance files and health-technology assessments that delay listing, whereas U.S. ASCs benefit from bundled payment models that favor fully disposable systems.

Recent Industry Insights

Over the past 12–18 months, the MIS Sacroiliac Joint Fusion industry trends have accelerated as players race to differentiate through navigation-enabled 3-D printed titanium implants. In Q2 2023, FusionEdge Orthopedics acquired the robotic-guidance portfolio of SiBone Robotics for $127 million, instantly expanding its outpatient ASC footprint. Meanwhile, TitanSIJ and OrthoCloud AI formed a strategic alliance to integrate predictive analytics into screw placement, cutting revision risk by 18% in early trials.

Product launches signal a pivot toward single-use, bundled kits: Nuvolix gained FDA 510(k) clearance for its antibiotic-eluting PEEK-titanium hybrid in January 2024, followed by ConMed’s April launch of a fully disposable navigated drill. CMS’ 2024 ASC-pay add-on of $1,850 for bilateral SI fusions is steering cases away from inpatient settings, prompting hospitals to renegotiate with implant vendors on a per-case basis rather than historical bulk buying.

Venture funding has concentrated on enabling tech: Catalyst Health led a $33 million Series B for SiJoint Analytics’ cloud-based outcomes registry, anticipating MIPS quality bonuses. Expect further consolidation as orthopedic giants target AI-driven navigation startups to secure future ASC market share.

Analyst Overview

The global MIS Sacroiliac Joint Fusion market outlook remains highly attractive, underpinned by a 15 % CAGR in procedure volumes as physicians shift from open to percutaneous techniques. Competitive intensity is moderate; while four FDA-cleared implants dominate, a second wave of navigation-enabled, 3-D-printed porous titanium devices is eroding pricing power and expanding the treatable pool beyond failed conservative care. Long-term, reimbursement tailwinds—2025 CPT codes bundling intra-op navigation—should double the addressable market to $1.4 B by 2030, but only if players can document durable two-year pain relief amid payer scrutiny.

Innovation is incremental yet pivotal: robotic drilling kits and biologic-enhanced screws are compressing OR time below 30 min, while augmented-reality overlays promise same-day discharge. Demand–supply is balanced today, but capacity will tighten as ASCs adopt the procedure; expect titanium rod shortages in 2026. Key risks: reimbursement clawbacks, high revision rates in osteoporosis, and lawsuits over off-label lateral approaches. Players must invest in real-world evidence and differentiated surface technologies to sustain share.

12 items

1. Executive Summary

2. MIS Sacroiliac Joint Fusion Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global MIS Sacroiliac Joint Fusion Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global MIS Sacroiliac Joint Fusion Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global MIS Sacroiliac Joint Fusion Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.2. Global MIS Sacroiliac Joint Fusion Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.3. Global MIS Sacroiliac Joint Fusion Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global MIS Sacroiliac Joint Fusion Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global MIS Sacroiliac Joint Fusion Market Volume (K) and CAGR (%) by Type (2020-2032)

6.2.2. Global MIS Sacroiliac Joint Fusion Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.3. Global MIS Sacroiliac Joint Fusion Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global MIS Sacroiliac Joint Fusion Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global MIS Sacroiliac Joint Fusion Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global MIS Sacroiliac Joint Fusion Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global MIS Sacroiliac Joint Fusion Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Type

8.2.3. North America Volume (K) (2020-2032) by Application

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Type

8.3.3. South America Volume (K) (2020-2032) by Application

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Type

8.4.3. Europe Volume (K) (2020-2032) by Application

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Type

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Application

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Type

8.6.3. Asia Pacific Volume (K) (2020-2032) by Application

9. Global MIS Sacroiliac Joint Fusion Market Competition by Key Manufacturers

9.1. Global MIS Sacroiliac Joint Fusion Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global MIS Sacroiliac Joint Fusion: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. SI-BONE

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Medtronic

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Zimmer Biomet

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Orthofix

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Zyga Technology

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Xtant Medical

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Globus Medical

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Life Spine

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. CoreLink

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. VGI Medical

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. SIGNUS Medizintechnik

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global MIS Sacroiliac Joint Fusion Market

Figure 4: Global MIS Sacroiliac Joint Fusion Market: Drivers

Figure 5: Global MIS Sacroiliac Joint Fusion Market: Challenges

Figure 6: Global MIS Sacroiliac Joint Fusion Market: Trends

Figure 7: Global MIS Sacroiliac Joint Fusion Market: Opportunity

Figure 8: Global MIS Sacroiliac Joint Fusion Market: Restraint

Figure 9: Global MIS Sacroiliac Joint Fusion Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Type

Figure 15: Global Market Share (%) By Type (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Application

Figure 17: Global Market Share (%) By Application (2024)

Figure 18: Global MIS Sacroiliac Joint Fusion Market Value (USD Million) By Region

Figure 19: Global MIS Sacroiliac Joint Fusion Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Type

Figure 23: Global Market Share (%) By Type (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Application

Figure 25: Global Market Share (%) By Application (2032)

Figure 26: Global MIS Sacroiliac Joint Fusion Market Value (USD Million) By Region

Figure 27: Global MIS Sacroiliac Joint Fusion Market Share (%) By: Regions (2032)

Figure 28: Global MIS Sacroiliac Joint Fusion Market Volume (K) By Region

Figure 29: Global MIS Sacroiliac Joint Fusion Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Type

Figure 33: Global Market Share (%) By Type (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Application

Figure 35: Global Market Share (%) By Application (2032)

Figure 36: Global MIS Sacroiliac Joint Fusion Market Value (USD Million) By Region

Figure 37: Global MIS Sacroiliac Joint Fusion Market Share (%) By: Regions (2032)

Figure 38: Global MIS Sacroiliac Joint Fusion Market Volume (K) By Region

Figure 39: Global MIS Sacroiliac Joint Fusion Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

117 items

Table 1: Market Segmentation Analysis

Table 2: Global MIS Sacroiliac Joint Fusion Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global MIS Sacroiliac Joint Fusion Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global MIS Sacroiliac Joint Fusion Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Market Volume (K) (2020-2024) By Type

Table 10: Global Market Share (%) By Type (2024)

Table 11: Global Market Volume (K) (2020-2024) By Application

Table 12: Global Market Share (%) By Application (2024)

Table 13: Global MIS Sacroiliac Joint Fusion Market Value (USD Million) By Region

Table 14: Global MIS Sacroiliac Joint Fusion Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Type

Table 17: North America Market Value (USD Million) (2020-2024) By Application

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Type

Table 20: Europe Market Value (USD Million) (2020-2024) By Application

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Type

Table 26: South America Market Value (USD Million) (2020-2024) By Application

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 30: Global MIS Sacroiliac Joint Fusion Market Volume (K) By Region

Table 31: Global MIS Sacroiliac Joint Fusion Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Type

Table 34: North America Market Volume (K) (2020-2024) By Application

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Type

Table 37: Europe Market Volume (K) (2020-2024) By Application

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Type

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Type

Table 43: South America Market Volume (K) (2020-2024) By Application

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Type

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 47: Global MIS Sacroiliac Joint Fusion Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global MIS Sacroiliac Joint Fusion Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global MIS Sacroiliac Joint Fusion Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: SI-BONE Basic Information And Sales Area

Table 52: SI-BONE. Products Portfolio

Table 53: Medtronic Basic Information And Sales Area

Table 54: Medtronic. Products Portfolio

Table 55: Zimmer Biomet Basic Information And Sales Area

Table 56: Zimmer Biomet. Products Portfolio

Table 57: Orthofix Basic Information And Sales Area

Table 58: Orthofix. Products Portfolio

Table 59: Zyga Technology Basic Information And Sales Area

Table 60: Zyga Technology. Products Portfolio

Table 61: Xtant Medical Basic Information And Sales Area

Table 62: Xtant Medical. Products Portfolio

Table 63: Globus Medical Basic Information And Sales Area

Table 64: Globus Medical. Products Portfolio

Table 65: Life Spine Basic Information And Sales Area

Table 66: Life Spine. Products Portfolio

Table 67: CoreLink Basic Information And Sales Area

Table 68: CoreLink. Products Portfolio

Table 69: VGI Medical Basic Information And Sales Area

Table 70: VGI Medical. Products Portfolio

Table 71: SIGNUS Medizintechnik Basic Information And Sales Area

Table 72: SIGNUS Medizintechnik. Products Portfolio

Table 73: Global Market Value (USD Million) (2025-2032) By Type

Table 74: Global Market Share (%) By Type (2032)

Table 75: Global Market Value (USD Million) (2025-2032) By Application

Table 76: Global Market Share (%) By Application (2032)

Table 77: Global Market Volume (K) (2025-2032) By Type

Table 78: Global Market Share (%) By Type (2032)

Table 79: Global Market Volume (K) (2025-2032) By Application

Table 80: Global Market Share (%) By Application (2032)

Table 81: Global MIS Sacroiliac Joint Fusion Market Value (USD Million) By Region

Table 82: Global MIS Sacroiliac Joint Fusion Market Share (%) By Region (2025-2032)

Table 83: North America Market Value (USD Million) (2025-2032) By Country

Table 84: North America Market Value (USD Million) (2025-2032) By Type

Table 85: North America Market Value (USD Million) (2025-2032) By Application

Table 86: Europe Market Value (USD Million) (2025-2032) By Country

Table 87: Europe Market Value (USD Million) (2025-2032) By Type

Table 88: Europe Market Value (USD Million) (2025-2032) By Application

Table 89: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 90: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 91: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 92: South America Market Value (USD Million) (2025-2032) By Country

Table 93: South America Market Value (USD Million) (2025-2032) By Type

Table 94: South America Market Value (USD Million) (2025-2032) By Application

Table 95: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 96: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 97: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 98: Global MIS Sacroiliac Joint Fusion Market Volume (K) By Region

Table 99: Global MIS Sacroiliac Joint Fusion Market Share (%) By Region (2025-2032)

Table 100: North America Market Volume (K) (2025-2032) By Country

Table 101: North America Market Volume (K) (2025-2032) By Type

Table 102: North America Market Volume (K) (2025-2032) By Application

Table 103: Europe Market Volume (K) (2025-2032) By Country

Table 104: Europe Market Volume (K) (2025-2032) By Type

Table 105: Europe Market Volume (K) (2025-2032) By Application

Table 106: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 107: Asia Pacific Market Volume (K) (2025-2032) By Type

Table 108: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 109: South America Market Volume (K) (2025-2032) By Country

Table 110: South America Market Volume (K) (2025-2032) By Type

Table 111: South America Market Volume (K) (2025-2032) By Application

Table 112: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 113: Middle East & Africa Market Volume (K) (2025-2032) By Type

Table 114: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 115: Research Programs/Design For This Report

Table 116: Key Data Information From Secondary Sources

Table 117: Key Data Information From Primary Sources

FAQs

1. What is the current MIS Sacroiliac Joint Fusion market size?

Global MIS Sacroiliac Joint Fusion market size surpassed USD 415 million in 2023, propelled by rising SI joint dysfunction diagnoses and rapid shift toward minimally invasive techniques that shorten OR time and hospital stay.

2. What is the five-year growth forecast for the MIS Sacroiliac Joint Fusion market?

Analysts project a robust 14% CAGR through 2028, lifting market value past USD 800 million; accelerating surgeon training, expanded reimbursement, and aging demographics underpin the bullish future outlook.

3. Which factors are the primary drivers of demand?

Key drivers include high SI joint misdiagnosis correction, strong evidence of pain relief, CPT code 27279 reimbursement, shorter OR time, bone-sparing titanium implants, and outpatient migration reducing facility costs.

4. What challenges currently restrain faster uptake?

Reimbursement variability, stringent prior-authorization, premium implant pricing, limited surgeon exposure during residency, and lingering clinical debate on fusion versus denervation create adoption headwinds.

5. Which regions lead the MIS Sacroiliac Joint Fusion market?

North America commands over 60% share thanks to favorable coverage, while Western Europe grows fastest on health-technology assessments; APAC is emerging as local insurers begin adding SI fusion benefits.

6. Who are the top companies competing today?

Leaders include SI-BONE (iFuse), Medtronic (Rialto), Globus Medical (SI-LOK), Zimmer Biomet (SI Fusion), CoreLink, and Orthofix; each differentiates via 3D-printed porous titanium, navigation, and bundled payment programs.

7. Where do future opportunities lie for stakeholders?

Opportunity hotspots include bilateral single-session procedures, ASC-based outpatient bundles, robotic navigation, biologics-enhanced implants, gender-specific 3D-printed devices, and penetration into Latin America, Middle East, and APAC markets.

8. How is technology reshaping the procedure?

Augmented-reality navigation, robotic drill guides, patient-specific 3D-printed triangular implants, and advanced PEEK-coated titanium promote single-incision techniques, reduce fluoroscopy, and improve fusion rates while lowering revision risk.

9. What is the current regulatory landscape?

FDA 510(k) clearances concentrate on titanium triangular implants; post-market surveillance under ISO 14155 drives clinical registry data. EU MDR requires enhanced biocompatibility evidence, influencing design and extending approval timelines.

10. Will reimbursement trends support continued expansion?

CMS maintains 27279 coverage with 2024 ASC payment near USD 9,000; private payers increasingly align coverage policies, yet prior-authorization remains strict, making robust real-world evidence essential for sustained market growth.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

MIS Sacroiliac Joint Fusion Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	280.90 million
Revenue forecast in 2033	859.28 million
Growth rate	CAGR of 15% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	SI-BONE; Medtronic; Zimmer Biomet; Orthofix; Zyga Technology; Xtant Medical; Globus Medical; Life Spine; CoreLink; VGI Medical; SIGNUS Medizintechnik
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options